Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Fish and Richardson
Accenture
Express Scripts
US Department of Justice
AstraZeneca
Cantor Fitzgerald
Fuji
Dow
Chubb

Generated: February 22, 2018

DrugPatentWatch Database Preview

Endo Pharms Inc Company Profile

« Back to Dashboard

Summary for Endo Pharms Inc
International Patents:234
US Patents:14
Tradenames:5
Ingredients:5
NDAs:5

Drugs and US Patents for Endo Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Pharms Inc NASCOBAL cyanocobalamin SPRAY, METERED;NASAL 021642-001 Jan 31, 2005 RX Yes Yes 7,879,349 ➤ Try a Free Trial Y ➤ Try a Free Trial
Endo Pharms Inc AVEED testosterone undecanoate INJECTABLE;INTRAMUSCULAR 022219-001 Mar 5, 2014 RX Yes Yes 8,338,395 ➤ Try a Free Trial ➤ Try a Free Trial
Endo Pharms Inc MEGACE ES megestrol acetate SUSPENSION;ORAL 021778-001 Jul 5, 2005 AB RX Yes Yes 6,592,903 ➤ Try a Free Trial Y ➤ Try a Free Trial
Endo Pharms Inc VALGANCICLOVIR HYDROCHLORIDE valganciclovir hydrochloride TABLET;ORAL 200790-001 Nov 4, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Endo Pharms Inc NASCOBAL cyanocobalamin SPRAY, METERED;NASAL 021642-001 Jan 31, 2005 RX Yes Yes 7,404,489 ➤ Try a Free Trial Y ➤ Try a Free Trial
Endo Pharms Inc NASCOBAL cyanocobalamin SPRAY, METERED;NASAL 021642-001 Jan 31, 2005 RX Yes Yes 8,940,714 ➤ Try a Free Trial ➤ Try a Free Trial
Endo Pharms Inc MEGACE ES megestrol acetate SUSPENSION;ORAL 021778-001 Jul 5, 2005 AB RX Yes Yes 9,107,827 ➤ Try a Free Trial ➤ Try a Free Trial
Endo Pharms Inc MEGACE ES megestrol acetate SUSPENSION;ORAL 021778-001 Jul 5, 2005 AB RX Yes Yes 9,040,088 ➤ Try a Free Trial ➤ Try a Free Trial
Endo Pharms Inc NASCOBAL cyanocobalamin SPRAY, METERED;NASAL 021642-001 Jan 31, 2005 RX Yes Yes 9,415,007 ➤ Try a Free Trial ➤ Try a Free Trial
Endo Pharms Inc AVEED testosterone undecanoate INJECTABLE;INTRAMUSCULAR 022219-001 Mar 5, 2014 RX Yes Yes 7,718,640 ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ENDO PHARMS INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Nasal Spray 500 mcg/spray ➤ Subscribe 4/28/2017
➤ Subscribe Injection 250 mg/mL ➤ Subscribe 6/11/2014

Non-Orange Book US Patents for Endo Pharms Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,850,995 Bioadhesive nanoparticulate compositions having cationic surface stabilizers ➤ Try a Free Trial
8,124,057 Propellant-based nanoparticulate dry powder aerosols and method of making ➤ Try a Free Trial
6,316,029 Rapidly disintegrating solid oral dosage form ➤ Try a Free Trial
6,811,767 Liquid droplet aerosols of nanoparticulate drugs ➤ Try a Free Trial
7,288,267 Bioadhesive nanoparticulate compositions having cationic surface stabilizers ➤ Try a Free Trial
8,323,641 Nanoparticulate compositions having lysozyme as a surface stabilizer ➤ Try a Free Trial
8,236,352 Glipizide compositions ➤ Try a Free Trial
7,695,739 In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions ➤ Try a Free Trial
6,969,529 Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers ➤ Try a Free Trial
7,244,451 Methods of making nanoparticulate drug compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Endo Pharms Inc Drugs

Supplementary Protection Certificates for Endo Pharms Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
02/028 Ireland ➤ Try a Free Trial PRODUCT NAME: VALGANCICLOVIR (2-(2-AMINO-1,6-DIHYDRO-6-OXO-PURIN-9-YL)- METHOXY-3-HYDROXY-1-PROPANYL-L-VALINATE) AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; NAT REGISTRATION NO/DATE: 50/150/1 20020913; FIRST REGISTRATION NO/DATE: NL 25992 20010920; PAEDIATRIC INVESTIGATION PLAN: P/0220/2013
C/GB02/027 United Kingdom ➤ Try a Free Trial PRODUCT NAME: 2-(2-AMINO-1,6-DIHYDRO-6-OXO-PURIN-9-YL)-METHOXY-3-HYDROXY-1-PROPANYL-L-VALINATE HYDROCHLORIDE (VALGANCICLOVIR HYDROCHLORIDE); REGISTERED: NL RVG 25992 20010920; UK PL 00031/0599 20020425
00071 Netherlands ➤ Try a Free Trial PRODUCT NAME: VALGANCICLOVIR, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET HYDROCHLORIDE; REGISTRATION NO/DATE: RVG 25992 20010920
C0003 France ➤ Try a Free Trial PRODUCT NAME: VALGANCICLOVIR AINSI QUE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET EN PARTICULIER LE CHLORHYDRATE; NAT. REGISTRATION NO/DATE: NL 27380 20021016; FIRST REGISTRATION: NL - RVG 25 992 20010920
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Farmers Insurance
Moodys
Julphar
Accenture
Johnson and Johnson
Colorcon
Cipla
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot